|
Altus Pharmaceuticals Stage: Venture, Growth Date of Investment: 2004 Web Site : http://www.altus.com Stock Symbol : ALTU |
 |
Altus Pharmaceuticals, Inc. is a leader in protein crystallization technology. Altus is focused on applying its proprietary crystallization technology to develop therapeutic products for gastrointestinal and metabolic diseases. In 2004, Warburg Pincus invested $32 million in Altus to lead a $51 million Series C financing. Founded in 1992 as a subsidiary of Vertex Pharmaceuticals and spun-out as an independent entity in 1999, Altus has multiple product candidates in development based on its technology platform. Its two most advanced programs are drugs to treat pancreatic insufficiency and growth hormone deficiency.
